These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31760102)

  • 41. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.
    Feher M; Gaszner B; Tamas A; Gil-Martinez AL; Fernandez-Villalba E; Herrero MT; Reglodi D
    Neurotox Res; 2018 May; 33(4):702-715. PubMed ID: 29230633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.
    Marzatico F; Café C; Taborelli M; Benzi G
    Neurochem Res; 1993 Oct; 18(10):1101-6. PubMed ID: 8255359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease.
    Roostalu U; Salinas CBG; Thorbek DD; Skytte JL; Fabricius K; Barkholt P; John LM; Jurtz VI; Knudsen LB; Jelsing J; Vrang N; Hansen HH; Hecksher-Sørensen J
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31704726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disorders.
    Wang Z; Luo XG; Gao C
    Transl Neurodegener; 2016; 5():17. PubMed ID: 27761236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys.
    Barcia C; Bautista V; Sánchez-Bahillo A; Fernández-Villalba E; Navarro-Ruis JM; Barreiro AF; Poza Y Poza M; Herrero MT
    Neuroendocrinology; 2003 Aug; 78(2):118-28. PubMed ID: 12915764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Franke SK; van Kesteren RE; Wubben JA; Hofman S; Paliukhovich I; van der Schors RC; van Nierop P; Smit AB; Philippens IH
    Neuroscience; 2016 Jan; 312():247-59. PubMed ID: 26431624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice].
    Jiang H; Qian ZM; Xie JX
    Sheng Li Xue Bao; 2003 Oct; 55(5):571-6. PubMed ID: 14566406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
    Mounayar S; Boulet S; Tandé D; Jan C; Pessiglione M; Hirsch EC; Féger J; Savasta M; François C; Tremblay L
    Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
    Herrero MT; Perez-Otaño I; Oset C; Kastner A; Hirsch EC; Agid Y; Luquin MR; Obeso JA; Del Rio J
    Neuroscience; 1993 Oct; 56(4):965-72. PubMed ID: 7904332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative study of striatum GABA concentrations and magnetic resonance spectroscopic imaging in Parkinson's disease monkeys.
    Huang L; Ren Y; Zeng Z; Ren H; Li S; He S; He F; Li X
    BMC Neurosci; 2019 Aug; 20(1):42. PubMed ID: 31395015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease.
    Ashkan K; Wallace BA; Mitrofanis J; Pollo C; Brard PY; Fagret D; Benabid AL
    Parkinsonism Relat Disord; 2007 Jul; 13(5):266-75. PubMed ID: 17196871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Bissonnette S; Muratot S; Vernoux N; Bezeau F; Calon F; Hébert SS; Samadi P
    Eur J Neurosci; 2014 Jul; 40(2):2406-16. PubMed ID: 24750443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.